Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Soy isoflavones can protect lung tissue from damage during radiation therapy for lung cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Oral minoxidil may help hair regrowth in female cancer survivors.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New treatments for skin aging will soon compete with current ones like tretinoin.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.